Institutional members access full text with Ovid®

Share this article on:

Propranolol for Hemangiomas of Infancy

Burton, Katharine

Journal of the Dermatology Nurses' Association: July/August 2010 - Volume 2 - Issue 4 - pp 154-155
doi: 10.1097/JDN.0b013e3181e8e401
Feature Articles

ABSTRACT: Hemangiomas of infancy can be challenging to treat, especially when complicated by size, location, or ulceration. The treatment of hemangiomas with propranolol has given dermatologists an exciting new treatment option. This article provides an overview of hemangiomas of infancy. Types of hemangiomas are discussed, including corresponding risk factors. The proliferation and the involution of hemangiomas are reviewed. Traditional treatment choices are discussed, including the care of ulcerated hemangiomas. The role of nursing in care of hemangiomas and the support of parents are reviewed. The treatment of infantile hemangiomas with propranolol is introduced and discussed as a promising new development in pediatric dermatology.

Katharine Burton, BA, RN, CCM (Certified Case Manager), 'Specially for Children Pediatric and Adolescent Dermatology, Dell Children's Medical Center of Central Texas, Austin, Texas.

Correspondence concerning this article should be addressed to Katharine Burton, BA, RN, CCM (Certified Case Manager), 'Specially for Children Pediatric and Adolescent Dermatology, Dell Children's Medical Center of Central Texas, Clinic Lead, RN IV, 1301 Barbara Jordan Blvd., Suite 200, Austin, TX 78723.E-mail: kburton@sfcaustin.com

© 2010 Lippincott Williams & Wilkins, Inc.